Antitumor efficiency of novel fluoro-substituted 6-amino-2- phenylbenzothiazole hydrochloride salts in vitro and in vivo

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 28, Issue 6, 2006, Pages 347-354

  Stojkovic, Ranko ^a   Karminski Zamola, G ^b   Racane L ^b   Tralic Kulenovic, V ^c   Glavas Obrovac, L ^d   Ivankovic, S ^a   Radacic, M ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

Author keywords

Antiproliferative antitumor activity; Fluoro substituted 6 amino 2 phenyl benzothiazole derivatives; In vitro in vivo

Indexed keywords

2 (FLUORO SUBSTITUTED PHENYL) 6 AMINOBENZOTHIAZOLE DERIVATIVE; 2 AMINO 5 NITROTHIOPHENOL; 3 FLUORBENZALDEHYDE DERIVATIVE; 4 FLUORBENZALDEHYDE DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; CHLORIDE; HYDROCHLOROTHIAZIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL PROLIFERATION; CELL SPECIFICITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DOSE RESPONSE; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; FIBROBLAST; FIBROSARCOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LARYNX CARCINOMA; MALE; MELANOMA; MOUSE; NONHUMAN; PROTEIN SYNTHESIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FIBROBLASTS; FIBROSARCOMA; HUMANS; INDICATORS AND REAGENTS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RNA, NEOPLASM; THIAZOLES;

EID: 33747108141     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2006.28.6.1003559     Document Type: Article

References (41)

1. Delmas, F., Di Giorgio, C., Robin, M. et al. In vitro activities of position 2 substitution-bearing 6-nitro- and 6-amino-benzothiazoles and their corresponding anthranitic acid derivatives against Leishmania infantum and Trichomonas vaginalis. Antimicrob Agents Chemother 2002, 46: 2588-94.
2. Turan-Zitouni, G., Demyrayak, S., Ozdemir, A., Kaplancikli, Z.A., Yildiz, M.T. Synthesis of some 2-[(benzazole-2-yl)thioacetylamino]thiazole derivatives and their antimicrobial activity and toxicity. Eur J Med Chem 2004, 39: 267-72.
3. Srimanth, K., Rao, V.R., Krishna, D.R. Synthesis and evaluation of anticancer activity of some imidazothiazolyl, imidazobenzothiazolyl and dihydroimidazothiazolyl coumarins. Arzneimittelforschung 2002, 52: 388-92.
4. Bradshaw, T.D., Stevens, M.F.G., Westwell, A.D. The discovery of the potent and selective antitumor agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds. Curr Med Chem 2001, 8: 203-10.
5. Magdolen, P., Zahradnik, P., Foltinova, P. Synthesis and antimicrobial activity of new 2-phenylethynylbenzothiazoles and related salts. Arzneimittelforsch 2000, 50: 1023-7.
6. Nadkarni, A.B., Kamath, R.V., Khadse, G.B. Synthesis and antihelmintic activity of substituted phenyl imidazo[2,1-b]benziothiazoles. Indian J Heterocyclic Chem 2000, 9: 309-10.
7. Akama, T., Ihida, H., Kimura, U., Gomi, K., Saito, H. Structure-activity relationships of the 7-substituents of 5,4′-diamino-6,8,3′- trifluoroflavone, a potent antitumor agent. J Med Chem 1998, 41: 2056-67.
8. Chua, M.S., Kashiyama, E., Bradshaw, T.D. et al. Role of CYP1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl) benzolhiazole (DF 203, NSC 674495) in human breast cancer cells. Cancer Res 2000, 60: 5196-203.
9. O'Brien, S.E., Browne, H.L., Bradshaw, T.D. et al. Antitumor benzothiazoles. Frontier molecular orbital analysis predicts bioactivation of 2-(4-aminophenyl)benzothiazoles to reactive intermediates by cytochrome P4501A1. Org Biomol Chem 2003, 1: 493-7.
10. Trapani, V., Patel, V., Leong, C.O. et al. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole ( 5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. Br J Cancer 2003, 88: 599-605.
11. Hutchinson, I., Bradshaw, T.D., Matthews, C.S., Stevens, M.F.G., Westwell, A.D. Antitumor benzothiazoles. Part 20: 3′-cyano and 3′-alkynyl-substituted 2-(4′ aminophenyl) benzothiazoles as new potent and selective analogues. Bioorg Med Chem Lett 2003, 13: 471-4.
12. Racanè, L., Tralić-Kulenović, V., Fiser-Jakić L., Boykin D.W., Karminski-Zamola, G. Synthesis of bis-substituted amidinobenzothiazoles as potential anti-HIV agents. Heterocycles 2001, 55: 2085-98.
13. Caleta, I., Grdisa, M., Mrvos-Sermek, D. Synthesis, crystal structure and antiproliferative evaluation of some new substituted benzothiazoles and styrylbenzothiazoles. Farmaco 2004, 59: 297-305.
14. Hutchinson, I., Chua, M.S., Browne, H.L. et al. Antitumor benzothiazoles. Part 14: Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles. J Med Chem 2001, 44: 1446-55.
15. Emerman, J.T., Siemiatkowski, J. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy. Cancer Res 1984, 44: 1327-32.
16. Fichtner, I., Tanneberger, S. Preoperative (neoadjuvant) chemotherapy in the murine Lewis lung carcinoma and possible implications for clinical use. Anticancer Res 1987, 7: 227-33.
17. Kerr, L.R., Grimm, M.S., Silva, W.A., Weinberg, J., Emerman, J.T. Effects of social housing condition on the response of the Shionogi mouse mammary carcinoma (SCI 15) to chemotherapy. Cancer Res 1997, 57: 1124-8.
18. Kerr, L.R., Wilkinson, D.A., Emerman, J.T., Weinberg, J. Interactive effects of psychosocial stressors and gender on mouse mammary tumor growth. Physiol Behav 1999, 66: 277-84.
19. Fujimoto-Ouchi, K., Tanaka, Y., Tominaga, T. Schedule dependency of antitumor activity in combination therapy with capecitabine/5′-deoxy-5- fluorouridin and docetaxel in breast cancer models. Clin Cancer Res 2001, 7: 1079-86.
20. Kerr, L.R., Hundal, R., Silva, W.A., Emermann, J.T., Weinberg, J. Effects of social housing condition on chemotherapeutic efficacy in a Shionogi carcinoma (SC1 15) mouse tumor model: Influences of temporal factors, tumor size and tumor growth rate. Psychosom Med 2001 ,63: 973-84.
21. Milross, C.G., Peters, L.J., Hunter, N.R., Mason, K.A., Milas, L. Sequence-dependent antitumor activity of paclitaxel (Taxol) and cisplatin in vivo. Int J Cancer 1995, 62: 599-604.
22. Milas, L., Wike, J., Hunter, N., Volpe, J., Basic, I. Macrophage content of murine sarcomas and carcinomas: Associations with tumor growth parameters and tumor radiocurability. Cancer Res 1987, 47: 1069-75.
23. Suit, H., Allam, A., Allalunis-Turner, J. et al. Is tumor cell radiation resistance correlated with metastatic ability? Cancer Res 1994, 54: 1736-41.
24. Meyn, R.E., Stephens, L.C., Hunter, N.R., Milas, L. Apoptosis in murine tumors treated with chemotherapy agents. Anti-Cancer Drugs 1995, 6: 443-50.
25. Wheelhouse, R.T., Shi, D.F., Wilman, D.E.V., Stevens, M.F.G. Antitumor benzothiazoles, Part 4: An NMR study of the sites of protonation of 2-(4-aminophenyl)benzothiazoles. J Chem Soc Perkin Trans I 1996, 2: 1271-4.
26. Horiuchi, N., Nakagawa, K., Sasaki, Y. et al. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay. Cancer Chemother Pharmacol 1988, 22: 246-50.
27. Liao, L., Kupchan, S.M., Horwitz, S.B. Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. Mol Pharmacol 1976, 12: 167-76.
28. Freshney, R.I. Culture of Animal Cells: A Manual of Basic Technique. Alan R. Liss: New York 1987, 179-85.
29. Teicher, B.A. In vivo tumor response end points. In: Tumor Models in Cancer Research. Ticher, B.A., (Ed.). Humana: Totowa, NJ 2002, 593-616.
30. Mruthyunjayaswamy, B.H.M., Shanthaveerappa, B.K. Synthesis and pharmacological evaluation of 3,5-disubstituted indole-2-[N-beta-(substituted benzopyran-2′-one-3′-carboxyl)]carboxy hydrazides and 2H-3-(various substituted indol-3′-yl)merhyl-1 ,3-benzothiazoles. Indian J Chem B Org 2000, 39: 433-9.
31. Shi, D.F., Bradshaw, T.D., Wrigley, S. et al. Antitumor benzothiazoles. Part 3: Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 1996, 39: 3373-84.
32. Kashiyama, E., Hutchinson, I., Chua, M.S. Antitumor benzothiazoles, Part 8: Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminopheny/)benzothiazoles. J Med Chem 1999, 42: 4172-84.
33. Hall, I.H., Peaty, N.J., Henry, J.R. et al. Investigations on the mechanism of action of the novel antitumor agents 2-benzothiazolyl, 2-benzoxazolyl, and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine. Arch Pharm 1999, 332: 115-23.
34. Weinstein, J.N., Myers, T.G., O'Connor, P.M. et al. An information-intensive approach to the molecular pharmacology of cancer. Science 1997, 275: 343-9.
35. Sener, E.A., Arpaci, O.T., Yalcin, I., Altanlar, N. Synthesis and microbiological activity of some novel 5-benzamido- and 5-phenylacetamido- substituted 2-phenylbenzoxazole derivatives. Farmaco 2000, 55: 397-405.
36. Oketani, K., Inoue, T., Murakami, M. Effects of E3040 an inhibitor of 5-lipoxygenase and tromboxane synthetase, on ret bowel damage induced by lipopolysacharide. Eur J Pharm 2001, 427: 159-66.
37. Oketani, K., Nagakura, N., Harada, K., Inoue, T. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and tromboxane A(2) synthetase, on ecosanoid production. Eur J Pharm 2001, 422: 209-16.
38. Jackson, J., Bolognese, R.B., Mangar, C.A. et al. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. Biochem Biophy Acta 1998, 1392: 145-52.
39. Daniel, T., Liu, O.H., Morrow, J.D., Crews, B.C., Marnett, I.J. Tromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 1999, 59: 4574-7.
40. Nie, D., Lamberti, M., Zacharek, A. Tromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun 2000, 267: 245-51.
41. Goldfarb, R.H., Kitson, R.P., Brunson, K.W. et al. Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles. Anticancer Res 1999, 19: 1663-7.